Sauthier Jéssica Tatiane, Dias Jéssica Barreto, Ferreira Cristiane de Sousa, Gomes Brendo de Oliveira Nascimento, Fraga Ketlyn Araujo, Pereira Elisa Cavalcante, da Silva Bruna Mendonça, Lima Letícia Ferreira, Gonçalves Irving Martins da Silveira, de Souza Audrien Alves Andrade, de Melo Marília Alves Figueira, Dos Santos Alexandre Araujo Cunha, Müller Beatriz de Lima Alessio, Moreira Aline Dos Santos, Resende Paola Cristina, Volotão Eduardo de Mello, da Silva Edson Elias
Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Genômica Aplicada e Bioinovações, Rio de Janeiro, RJ, Brasil.
Mem Inst Oswaldo Cruz. 2025 Jun 27;120:e240230. doi: 10.1590/0074-02760240230. eCollection 2025.
Human enterovirus C99 (HEV-C99) is a member of the species Enterovirus C. Currently, three complete genomes of HEV-C99 were reported in Brazil, all obtained from children with gastroenteritis symptoms. Notwithstanding, no HEV-C99 complete genome associated with AFP cases in Brazil have been analysed so far.
In light of this, molecular characterisation of an HEV-C99 isolated from a case of acute flaccid paralysis (AFP) in Brazil was carried out.
In 2005, an HEV-C99 strain was isolated from a 2-year-old female child in Santa Catarina State, Brazil, showing classic symptoms of AFP. Stool sample was inoculated into specific cell cultures. Viral RNA was extracted, and polymerase chain reaction (PCR) were performed to amplify the VP1 gene; the sequence was analysed for molecular identification. Subsequently, the complete genome was sequenced and analysed, including a phylogenetic analysis of the VP1 gene.
The isolate, denominated HEV-C99/33322/BRA/2005 presented 85.85% identity to other HEV-C99 strains also described in Brazil, subsequently. Besides, the isolate grouped together with HEV-C99 cluster C strains. To our knowledge, this was the first described HEV-C99 isolated from an AFP case in Brazil.
The data generated in this study bolster the role of HEV-C99 as an etiologic agent of AFP. Furthermore, this research enhances our knowledge regarding the HEV-C99 genetic diversity.
人类肠道病毒C99(HEV-C99)是肠道病毒C种的一个成员。目前,巴西报告了3个HEV-C99的完整基因组,均来自有肠胃炎症状的儿童。尽管如此,迄今为止,巴西尚未分析过与急性弛缓性麻痹(AFP)病例相关的HEV-C99完整基因组。
鉴于此,对从巴西一例急性弛缓性麻痹病例中分离出的HEV-C99进行了分子特征分析。
2005年,从巴西圣卡塔琳娜州一名出现AFP典型症状的2岁女童中分离出一株HEV-C99毒株。将粪便样本接种到特定细胞培养物中。提取病毒RNA,进行聚合酶链反应(PCR)以扩增VP1基因;对序列进行分析以进行分子鉴定。随后,对完整基因组进行测序和分析,包括对VP1基因的系统发育分析。
分离株命名为HEV-C99/33322/BRA/2005,与巴西后来描述的其他HEV-C99毒株的同一性为85.85%。此外,该分离株与HEV-C99 C簇毒株归为一组。据我们所知,这是巴西首次从AFP病例中分离出的HEV-C99。
本研究产生的数据支持HEV-C99作为AFP病原体的作用。此外,这项研究增强了我们对HEV-C99遗传多样性的认识。